Malcolm Richardson

23.9k total citations · 4 hit papers
263 papers, 11.3k citations indexed

About

Malcolm Richardson is a scholar working on Infectious Diseases, Epidemiology and Cell Biology. According to data from OpenAlex, Malcolm Richardson has authored 263 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 178 papers in Infectious Diseases, 141 papers in Epidemiology and 52 papers in Cell Biology. Recurrent topics in Malcolm Richardson's work include Antifungal resistance and susceptibility (167 papers), Fungal Infections and Studies (98 papers) and Nail Diseases and Treatments (50 papers). Malcolm Richardson is often cited by papers focused on Antifungal resistance and susceptibility (167 papers), Fungal Infections and Studies (98 papers) and Nail Diseases and Treatments (50 papers). Malcolm Richardson collaborates with scholars based in United Kingdom, Finland and United States. Malcolm Richardson's co-authors include David W. Denning, David W. Warnock, Cornelia Lass‐Flörl, Elizabeth M. Johnson, Riina Rautemaa‐Richardson, Iain Page, Caroline B. Moore, G. S. Shankland, William Hope and H. R. Ashbee and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Malcolm Richardson

261 papers receiving 10.8k citations

Hit Papers

EUCAST Definitive Document EDef 7.1: method for the deter... 2008 2026 2014 2020 2008 2011 2013 2017 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts
    2008 549 citations J. L. Rodríguez-Tudela, Maiken Cavling Arendrup et al. Clinical Microbiology and Infection profile →
  2. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
    2011 540 citations B. Dupont, Cornelia Lass‐Flörl et al. Clinical Microbiology and Infection profile →
  3. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
    2013 521 citations H. R. Ashbee, R.A. Barnes et al. Journal of Antimicrobial Chemotherapy profile →
  4. Biofilm-Forming Capability of Highly Virulent, Multidrug-ResistantCandida auris
    2017 322 citations Elizabeth M. Johnson, Malcolm Richardson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malcolm Richardson United Kingdom 55 7.5k 6.1k 1.4k 1.4k 1.2k 263 11.3k
David W. Warnock United Kingdom 61 8.4k 1.1× 7.0k 1.2× 1.2k 0.9× 1.6k 1.2× 705 0.6× 205 11.8k
Arnaldo Lopes Colombo Brazil 67 12.1k 1.6× 10.0k 1.6× 1.7k 1.3× 2.2k 1.6× 953 0.8× 290 15.1k
Maiken Cavling Arendrup Denmark 61 11.1k 1.5× 9.0k 1.5× 1.5k 1.1× 2.5k 1.8× 843 0.7× 245 14.8k
E. Anaissie United States 52 5.2k 0.7× 4.5k 0.7× 1.3k 1.0× 1.3k 0.9× 591 0.5× 137 9.0k
Manuel Cuenca‐Estrella Spain 62 10.2k 1.4× 8.1k 1.3× 1.0k 0.7× 2.4k 1.8× 573 0.5× 204 12.4k
Márcio Nucci Brazil 54 8.1k 1.1× 6.8k 1.1× 854 0.6× 1.7k 1.3× 822 0.7× 237 11.6k
S. A. Messer United States 75 15.2k 2.0× 12.0k 2.0× 1.5k 1.1× 1.8k 1.3× 1.0k 0.9× 201 17.2k
Shawn R. Lockhart United States 67 11.4k 1.5× 9.5k 1.6× 2.1k 1.5× 1.7k 1.3× 600 0.5× 252 14.0k
Emmanuel Roilides Greece 62 10.7k 1.4× 9.3k 1.5× 1.3k 1.0× 968 0.7× 1.2k 1.0× 432 15.8k
Nathan P. Wiederhold United States 56 6.7k 0.9× 5.4k 0.9× 1.2k 0.9× 1.8k 1.4× 539 0.5× 307 9.7k

Countries citing papers authored by Malcolm Richardson

Since Specialization
Citations

This map shows the geographic impact of Malcolm Richardson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Richardson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Richardson more than expected).

Fields of papers citing papers by Malcolm Richardson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm Richardson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Richardson. The network helps show where Malcolm Richardson may publish in the future.

Co-authorship network of co-authors of Malcolm Richardson

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm Richardson. A scholar is included among the top collaborators of Malcolm Richardson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm Richardson. Malcolm Richardson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frazer, Lilyann Novak, et al.. (2024). Development of a novel mycobiome diagnostic for fungal infection. BMC Microbiology. 24(1). 3 indexed citations
2.
Maertens, Johan, Monica A. Slavin, Martin Hoenigl, et al.. (2024). Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases—a debate. Journal of Antimicrobial Chemotherapy. 79(8). 1786–1793. 2 indexed citations
3.
Lau, Jeffrey, et al.. (2023). Comparison of β-1-3-D-Glucan and Candida Mannan Biomarker Assays with Serological Tests for the Diagnosis of Candidemia. Journal of Fungi. 9(8). 813–813. 6 indexed citations
4.
Ocansey, Bright, Peter Puplampu, Rita Oladele, et al.. (2022). Improving awareness, diagnosis and management of invasive fungal infections in Ghana: establishment of the Ghana Medical Mycology Society. Medical Mycology. 60(9). 2 indexed citations
5.
Rautemaa‐Richardson, Riina, et al.. (2021). Molecular Epidemiology of Aspergillus fumigatus in Chronic Pulmonary Aspergillosis Patients. Journal of Fungi. 7(2). 152–152. 9 indexed citations
6.
Gago, Sara, et al.. (2021). Differential Proinflammatory Responses to Aspergillus fumigatus by Airway Epithelial Cells In Vitro Are Protease Dependent. Journal of Fungi. 7(6). 468–468. 13 indexed citations
7.
Loughlin, Laura, Thomas P Hellyer, P. Lewis White, et al.. (2020). Pulmonary Aspergillosis in Patients with Suspected Ventilator-Associated Pneumonia in UK ICUs. American Journal of Respiratory and Critical Care Medicine. 202(8). 1125–1132. 30 indexed citations
8.
Dryden, Matthew, Jonathan Cooke, Rami J. Salib, et al.. (2017). Reactive oxygen: A novel antimicrobial mechanism for targeting biofilm-associated infection. Journal of Global Antimicrobial Resistance. 8. 186–191. 38 indexed citations
9.
Ashbee, H. R., R.A. Barnes, Elizabeth M. Johnson, et al.. (2013). Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. Journal of Antimicrobial Chemotherapy. 69(5). 1162–1176. 521 indexed citations breakdown →
10.
Arıkan, S., Francesco Barchiesi, J. Bille, et al.. (2009). The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) EUCAST Technical Note on fluconazole.. Clinical Microbiology and Infection. 12 indexed citations
11.
Arıkan, S., Francesco Barchiesi, J. Bille, et al.. (2009). Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds.. Clinical Microbiology and Infection. 15(1). 103–103. 111 indexed citations
12.
Migliori, Giovanni Battista, Malcolm Richardson, Giovanni Sotgiu, et al.. (2009). A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis. European Respiratory Journal. 34(2). 387–393. 123 indexed citations
13.
Rodríguez-Tudela, J. L., Maiken Cavling Arendrup, Francesco Barchiesi, et al.. (2008). EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clinical Microbiology and Infection. 14(4). 398–405. 549 indexed citations breakdown →
14.
Rodríguez-Tudela, J. L., Francesco Barchiesi, Jacques Billé, et al.. (2003). Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Clinical Microbiology and Infection. 9(8). i–viii. 164 indexed citations
15.
Morris, Gordon A., M Kokki, Kenneth E. Anderson, & Malcolm Richardson. (2000). Sampling of Aspergillus spores in air. Journal of Hospital Infection. 44(2). 81–92. 83 indexed citations
16.
Barnes, Rosemary A., David W. Denning, E. G. V. Evans, et al.. (1996). Fungal infections: a survey of laboratory services for diagnosis and treatment.. PubMed. 6(5). R69–75. 11 indexed citations
17.
Bhattacharyya, Tapan K., et al.. (1996). Morphological transition in Pityrosporum ovale.. Journal of Investigative Dermatology. 3(107). 507. 1 indexed citations
18.
19.
Shankland, G. S., Malcolm Richardson, & Gordon N. Dutton. (1986). Source of infection in candida endophthalmitis in drug addicts.. BMJ. 292(6528). 1106.2–1107. 25 indexed citations
20.
White, L. O., et al.. (1977). Circulating antigen ofAspergillus fumigatusin cortisone-treated mice challenged with conidia: Detection by counterimmunoelectrophoresis. FEMS Microbiology Letters. 2(3). 153–156. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David W. Warnock Breakdown of academic impact, for papers by Arnaldo Lopes Colombo Breakdown of academic impact, for papers by Maiken Cavling Arendrup Breakdown of academic impact, for papers by E. Anaissie Breakdown of academic impact, for papers by Manuel Cuenca‐Estrella Breakdown of academic impact, for papers by Márcio Nucci Breakdown of academic impact, for papers by S. A. Messer Breakdown of academic impact, for papers by Shawn R. Lockhart Breakdown of academic impact, for papers by Emmanuel Roilides Breakdown of academic impact, for papers by Nathan P. Wiederhold
Rankless by CCL
2026